91 related articles for article (PubMed ID: 2909691)
1. Tumor-infiltrating lymphocytes and histocompatibility antigens in primary intracranial germinomas.
Saito T; Tanaka R; Kouno M; Washiyama K; Abe S; Kumanishi T
J Neurosurg; 1989 Jan; 70(1):81-5. PubMed ID: 2909691
[TBL] [Abstract][Full Text] [Related]
2. In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers.
Miescher S; Whiteside TL; de Tribolet N; von Fliedner V
J Neurosurg; 1988 Mar; 68(3):438-48. PubMed ID: 3257792
[TBL] [Abstract][Full Text] [Related]
3. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
List AF; Spier CM; Miller TP; Grogan TM
Leukemia; 1993 Mar; 7(3):398-403. PubMed ID: 7680400
[TBL] [Abstract][Full Text] [Related]
4. [Separation and functional analysis of tumor-infiltrating lymphocytes in brain tumor tissues].
Saito T; Tanaka R; Takai N; Hara N; Yoshida S
No To Shinkei; 1988 Dec; 40(12):1137-42. PubMed ID: 3266842
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of natural killer cells in tumor-infiltrating lymphocytes of primary intracranial germinomas.
Vaquero J; Coca S; Magallón R; Pontón P; Martinez R
J Neurosurg; 1990 Apr; 72(4):616-8. PubMed ID: 1690793
[TBL] [Abstract][Full Text] [Related]
6. Dysgerminoma of the ovary. An immunohistochemical study of tumor-infiltrating lymphoreticular cells and tumor cells.
Dietl J; Horny HP; Ruck P; Kaiserling E
Cancer; 1993 Apr; 71(8):2562-8. PubMed ID: 8453580
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of tumor-infiltrating lymphocytes and major histocompatibility antigens in human gliomas and metastatic brain tumors.
Saito T; Tanaka R; Yoshida S; Washiyama K; Kumanishi T
Surg Neurol; 1988 Jun; 29(6):435-42. PubMed ID: 3259730
[TBL] [Abstract][Full Text] [Related]
8. [Fundamental and clinical aspects of adoptive immunotherapy with tumor-infiltrating lymphocytes].
Yahata G; Okada Y; Honda S; Tanaka K; Tokunaga A; Takahashi T; Seidou T; Takeuchi S
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1474-82. PubMed ID: 2471459
[TBL] [Abstract][Full Text] [Related]
9. Treatment of murine primary brain tumors with systemic interleukin-2 and tumor-infiltrating lymphocytes.
Saris SC; Spiess P; Lieberman DM; Lin S; Walbridge S; Oldfield EH
J Neurosurg; 1992 Mar; 76(3):513-9. PubMed ID: 1738033
[TBL] [Abstract][Full Text] [Related]
10. [Local immunotherapy with OK-432 for malignant gliomas--immunohistochemical analysis of chronological changes of tumor tissues].
Saito T; Tanaka R; Sekiguchi K; Yoshida S; Washiyama K; Yamada N; Takeda N
No To Shinkei; 1988 Jul; 40(7):609-15. PubMed ID: 3224036
[TBL] [Abstract][Full Text] [Related]
11. Immunohistological analysis of tumour infiltrating lymphocytes in seminoma using monoclonal antibodies.
Nakanoma T; Nakamura K; Deguchi N; Fujimoto J; Tazaki H; Hata J
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):409-13. PubMed ID: 1455691
[TBL] [Abstract][Full Text] [Related]
12. Characterization of lymphoid cells isolated from human gliomas.
Farmer JP; Antel JP; Freedman M; Cashman NR; Rode H; Villemure JG
J Neurosurg; 1989 Oct; 71(4):528-33. PubMed ID: 2795172
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors.
Bodey B; Bodey B; Siegel SE
Mod Pathol; 1995 Apr; 8(3):333-8. PubMed ID: 7617661
[TBL] [Abstract][Full Text] [Related]
14. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.
Nielsen JS; Sahota RA; Milne K; Kost SE; Nesslinger NJ; Watson PH; Nelson BH
Clin Cancer Res; 2012 Jun; 18(12):3281-92. PubMed ID: 22553348
[TBL] [Abstract][Full Text] [Related]
15. Immunomagnetic separation of infiltrating T lymphocytes from brain tumors.
Bosnes V; Hirschberg H
J Neurosurg; 1989 Aug; 71(2):218-23. PubMed ID: 2664096
[TBL] [Abstract][Full Text] [Related]
16. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
[TBL] [Abstract][Full Text] [Related]
17. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
18. High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
Chen H; Li G; Cui Y; Zhang Q; Li B; Liu X
Cancer Med; 2023 Mar; 12(5):5450-5460. PubMed ID: 36259639
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
[TBL] [Abstract][Full Text] [Related]
20. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS
Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
